SCHEMBL12473035

SCHEMBL12473035

CC1(C)CCC2=C(O1)c1ccccc1C(=Nc1ccc([N+](=O)[O-])cc1)C2=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MALT1 Q9UDY8 9/20 0.61
▸ MAPT P10636 4/20 0.58
▸ SMN1; SMN2 Q16637 4/20 0.58
▸ KMT2A Q03164 3/20 0.58
▸ IDO1 P14902 2/20 0.58
▸ NQO1 P15559 2/20 0.58
▸ MEN1 O00255 2/20 0.58
▸ MAPK1 P28482 2/20 0.58
▸ RAB9A P51151 2/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ CES2 O00748 1/20 0.58
▸ GMNN O75496 1/20 0.58
▸ TDP2 O95551 1/20 0.58
▸ ALDH1A1 P00352 1/20 0.58
▸ LMNA P02545 1/20 0.58
▸ TP53 P04637 1/20 0.58
▸ CYP1A2 P05177 1/20 0.58
▸ GLA P06280 1/20 0.58
▸ CYP3A4 P08684 1/20 0.58
▸ CYP2D6 P10635 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18774056 0.87 MALT1 (0.65) MALT1MAPTSMN1; SMN2KMT2AIDO1
SCHEMBL12473069 0.87 MALT1 (0.65) MALT1MAPTSMN1; SMN2KMT2AIDO1
SCHEMBL12473212 0.87 MALT1 (0.68) MALT1MAPTSMN1; SMN2KMT2AIDO1
SCHEMBL12473163 0.85 MALT1 (0.62) MALT1MAPTSMN1; SMN2KMT2AIDO1
SCHEMBL12473165 0.83 MALT1 (0.61) MALT1MAPTSMN1; SMN2KMT2AIDO1
SCHEMBL18774057 0.83 MALT1 (0.60) MALT1MAPTSMN1; SMN2KMT2AIDO1
SCHEMBL878201 0.81 MALT1 (0.56) MALT1MAPTSMN1; SMN2KMT2AIDO1
SCHEMBL878200 0.81 MALT1 (0.56) MALT1MAPTSMN1; SMN2KMT2AIDO1
SCHEMBL878518 0.81 MALT1 (0.56) MALT1MAPTSMN1; SMN2KMT2AIDO1
SCHEMBL18774148 0.80 MALT1 (0.55) MALT1MAPTSMN1; SMN2KMT2AIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2619331-B1 METHODS OF TREATING CANCER COMPRISING TARGETING NQO1 UNIV TEXAS (US) 2018-02-28 — — EP disclosed
EP-2619331-A1 METHODS OF TREATING CANCER COMPRISING TARGETING NQO1 The Board of Regents of The University of Texas System (US) 2013-07-31 — — EP disclosed
WO-2012040513-A1 COMPOSITIONS AND METHODS FOR THE DELIVERY OF BETA LAPACHONE THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2012-03-29 — — WO disclosed
WO-2012040492-A1 METHODS OF TREATING CANCER COMPRISING TARGETING NQO1 THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2012-03-29 — — WO disclosed
Send feedback